Literature DB >> 1394133

p53 mutations in breast cancer.

C Coles1, A Condie, U Chetty, C M Steel, H J Evans, J Prosser.   

Abstract

We have identified and analyzed 41 mutations in p53 in sporadic breast tumors from 136 unselected breast cancer patients and estimate that approximately 40% of such tumors contain p53 mutations. The frequency of G-T transversions and the incidence of guanosine mutations in the nontranscribed strand of the p53 gene were found to be higher than expected, and we suggest, therefore, that exogenous carcinogens have an etiological role in sporadic breast cancers. Mutations were recorded in 44 codons of the p53 gene, with no obvious mutational hot-spots, although mutations at codons 175, 194, 273, and 280 accounted for 25% of the changes. One germ-line mutation was found in 136 patients and so we conclude that constitutional mutation of p53 may be an uncommon etiological factor in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394133

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  63 in total

Review 1.  Regulation of p53 and its targets during involution of the mammary gland.

Authors:  D J Jerry; J Pinkas; C Kuperwasser; E S Dickinson; S P Naber
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

Review 2.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

3.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

Review 4.  Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.

Authors:  Richard Marcotte; William J Muller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-24       Impact factor: 2.673

5.  Altered mammary gland development in the p53+/m mouse, a model of accelerated aging.

Authors:  Catherine E Gatza; Melissa Dumble; Frances Kittrell; David G Edwards; Robert K Dearth; Adrian V Lee; Jianming Xu; Daniel Medina; Lawrence A Donehower
Journal:  Dev Biol       Date:  2007-10-12       Impact factor: 3.582

6.  p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis.

Authors:  L Sivaraman; O M Conneely; D Medina; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

7.  Human immunodeficiency virus type 1-like DNA sequences and immunoreactive viral particles with unique association with breast cancer.

Authors:  E M Rakowicz-Szulczynska; B Jackson; A M Szulczynska; M Smith
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

8.  Novel pattern of P53 mutation in breast cancers from Austrian women.

Authors:  A Hartmann; G Rosanelli; H Blaszyk; J M Cunningham; R M McGovern; J J Schroeder; D J Schaid; J S Kovach; S S Sommer
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

9.  Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.

Authors:  S Venkatachalam; Y P Shi; S N Jones; H Vogel; A Bradley; D Pinkel; L A Donehower
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

10.  Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors.

Authors:  Zidong Li; Bo Chen; Yiqing Wu; Feng Jin; Yongjing Xia; Xiangjun Liu
Journal:  BMC Cancer       Date:  2010-03-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.